Piel de Toro could start trading on the Alternative Market - MAB
Piel de Toro podría comenzar a cotizar en el Mercado Alternativo Bursátil (MAB)
Intel ID : 222221
| Synopsis |
|
Piel de Toro, based in Sevilla, could start trading on the Alternative Market - MAB at the end of 2015 beginning of 2016. This transaction will include 15% of the capital. With the resources the company will finance and strengthen its international expansion in the UK and in Peru, Chile and Panama. The company could be finalizing its entrance in the Indian market, and could also be interested in entering Mexico, United States and Qatar.
(content in spanish)
La empresa sevillana Piel de Toro podría comenzar a cotizar en el Mercado Alternativo Bursátil (MAB) a finales de 2015 o principios de 2016 en una operación que afectará al 15% del capital. Los recursos que se obtengan podrían destinarse a financiar y consolidar su expansión internacional en Reino Unido y países latinoamericanos como Perú, Chile o Panamá. La compañía, que podría estar ultimando su entrada en el mercado indio, podría tener también intenciones de abrir tiendas en México, Estados Unidos y Qatar. |
|
||||
| Intel ID | 222221 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
| Date |
|
||
| Country | ![]() |
||
| Region | |||
| Continent | ![]() |
||
| Geography | ![]() |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | ![]() |
Issuer
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
10.01.03 Distributors & Wholesalers (B2B) 10 Business Services / 10.01 Business & Professional Support Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.
